Du Ping, Tao Xuelian, Harati Javad, Shi Yue, Xiao Liang, Li Xian, Pan Haobo, Wang Peng-Yuan
Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, China.
Center for Human Tissues and Organs Degeneration, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, China.
Stem Cell Res Ther. 2024 Dec 18;15(1):473. doi: 10.1186/s13287-024-04085-5.
Human platelet lysate (hPL) has emerged as a promising serum substitute to enhance the self-renewal and multipotency of human mesenchymal stem cells (MSCs). Despite its potential, the specific biological mechanisms by which hPL influences MSC phenotypes remain inadequately understood.
We investigated the biological signaling activated by hPL in two common types of human MSCs: bone marrow-derived MSCs (BMSCs) and adipose-derived MSCs (ASCs). Cell adhesion and cell-matrix interaction were assessed through immunofluorescence staining and western blotting. The impact of hPL on lipid droplet formation in MSCs was thoroughly examined using oil red O/BODIPY staining, semi-quantitative analysis, and qRT-PCR. RNA sequencing and intracellular inhibition assays were also performed to elucidate the mechanisms by which hPL modulates MSC behavior.
MSCs cultured in hPL medium demonstrated a reduction in cell size, spreading area, and vinculin puncta, while enhancing cell proliferation and lipid droplet accumulation compared to those cultured in control media. Notably, the lipid droplets in hPL-treated MSCs were significantly smaller than those in adipocyte-like cells differentiated from MSCs, highlighting hPL's distinctive role in lipid production. Gene and protein expression profiles of hPL-treated MSCs differed from those in adipocyte-like cells. An angiogenic factor array revealed that hPL-MSCs had a distinct angiogenic factor profile compared to FBS-MSCs, with VEGF expression closely linked to HIF-1α expression. RNA-seq data identified approximately 1,900 differentially expressed genes (DEGs) between hPL-MSCs and FBS-MSCs, with enrichment in focal adhesion, ECM-receptor interaction, and PI3K-Akt/MAPK signaling pathways. Inhibition of MAPK phosphorylation significantly hampered lipid formation in hPL-MSCs, underscoring the pivotal role of MAPK signaling in hPL-driven adipogenesis.
This study reveals the biological mechanisms by which hPL infleunces MSC behavior and differentiation, offering new insights into its potential application in regenerative medicine and tissue engineering.
人血小板裂解物(hPL)已成为一种有前景的血清替代物,可增强人间充质干细胞(MSC)的自我更新和多能性。尽管其具有潜力,但hPL影响MSC表型的具体生物学机制仍未得到充分理解。
我们研究了hPL在两种常见类型的人MSC中激活的生物信号:骨髓来源的MSC(BMSC)和脂肪来源的MSC(ASC)。通过免疫荧光染色和蛋白质印迹评估细胞粘附和细胞-基质相互作用。使用油红O/硼二吡咯染色、半定量分析和qRT-PCR全面检查hPL对MSC中脂滴形成的影响。还进行了RNA测序和细胞内抑制试验,以阐明hPL调节MSC行为的机制。
与在对照培养基中培养的MSC相比,在hPL培养基中培养的MSC细胞大小、铺展面积和纽蛋白斑点减少,同时细胞增殖和脂滴积累增强。值得注意的是,hPL处理的MSC中的脂滴明显小于从MSC分化而来的脂肪样细胞中的脂滴,突出了hPL在脂质产生中的独特作用。hPL处理的MSC的基因和蛋白质表达谱与脂肪样细胞中的不同。血管生成因子阵列显示,与FBS-MSC相比,hPL-MSC具有独特的血管生成因子谱,VEGF表达与HIF-1α表达密切相关。RNA-seq数据确定了hPL-MSC和FBS-MSC之间约1900个差异表达基因(DEG),在粘着斑、ECM-受体相互作用和PI3K-Akt/MAPK信号通路中富集。抑制MAPK磷酸化显著阻碍了hPL-MSC中的脂质形成,强调了MAPK信号在hPL驱动的脂肪生成中的关键作用。
本研究揭示了hPL影响MSC行为和分化的生物学机制,为其在再生医学和组织工程中的潜在应用提供了新的见解。